About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multihance Versus Magnevist in Breast MRI

NCT00486473·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bracco Diagnostics, Inc

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Provides written informed consent
Female
Age 18 years or older
Suspicious or known breast lesion based on results from mammography or ultrasound
Planned to undergo histological diagnosis of breast lesion by having a non surgical biopsy or breast surgery within 30 days after the MRI exam

You may not be if

Body weight \> 100 kg
Pregnant or lactating
Server or end-stage organ failure
Moderate to severe renal impairment
Undergoing radiotherapy or completed radiotherapy in the last 18 months
Chemotherapy within 6 months of the 1st MRI exam

The record

StatusCompleted

PhasePhase 3

Taking part130

StartedJul 2007

UpdatedJul 15, 2010

Conditions

Where1

Rome, Italy

Clareo Health | Multihance Versus Magnevist in Breast MRI